25 companies filed certified H-1B applications for Director, Biostatistics roles (FY2026), ranked by filing volume from U.S. Department of Labor disclosure data.
| # | Employer | H-1B filings | Avg. wage |
|---|---|---|---|
| 1 | Merck & Co. Inc. | 12 | $83,582 |
| 2 | NOVARTIS PHARMACEUTICALS CORPORATION | 8 | $141,565 |
| 3 | GENESIS RESEARCH LLC | 4 | $109,375 |
| 4 | Jazz Pharmaceuticals, Inc. | 3 | $179,000 |
| 5 | Sarepta Therapeutics, Inc. | 2 | $225,000 |
| 6 | JUNO THERAPEUTICS INC. | 2 | $220,000 |
| 7 | BRISTOL-MYERS SQUIBB COMPANY | 2 | $271,087 |
| 8 | GERON CORPORATION | 2 | $222,719 |
| 9 | ITI, Inc. | 2 | $186,430 |
| 10 | Pfizer Inc. | 2 | $161,450 |
| 11 | NEKTAR THERAPEUTICS | 1 | $113,534 |
| 12 | PepGen Inc. | 1 | $255,000 |
| 13 | Quidel Corporation | 1 | $155,000 |
| 14 | Teva Branded Pharmaceutical Products R&D, Inc. | 1 | $190,026 |
| 15 | Alexion Pharmaceuticals, Inc. | 1 | $228,800 |
| 16 | Vanda Pharmaceuticals, Inc | 1 | $230,000 |
| 17 | Amgen Incorporated | 1 | $179,303 |
| 18 | AXIO RESEARCH LLC | 1 | $142,800 |
| 19 | BlueRock Therapeutics, LP | 1 | $230,000 |
| 20 | CHILTERN INTERNATIONAL INC. | 1 | $137,259 |
| 21 | CRISPR Therapeutics, Inc. | 1 | $200,000 |
| 22 | CYTEL INC. | 1 | $167,055 |
| 23 | Exelixis, Inc. | 1 | $200,000 |
| 24 | KINIKSA PHARMACEUTICALS CORP | 1 | $137,966 |
| 25 | Leap Therapeutics Inc. | 1 | $210,000 |
| State | H-1B filings |
|---|---|
| New Jersey | 19 |
| Pennsylvania | 11 |
| Massachusetts | 9 |
| California | 6 |
| Washington | 5 |
Counts are certified H-1B Labor Condition Applications (LCAs) from public U.S. Department of Labor disclosure data. Wages shown are the offered annual wage on the filing, not a guarantee of pay.